Skip to content

Treatment of Knee Osteoarthritis: Neuromuscular Electrical Stimulation and Low-level Laser.

Neuromuscular Electrical Stimulation and Low-level Laser: Combined Use for the Treatment of Knee Osteoarthritis in Elderly

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02067871
Enrollment
44
Registered
2014-02-20
Start date
2012-03-31
Completion date
2012-12-31
Last updated
2014-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

neuromuscular electrical stimulation, low-level laser therapy, knee osteoarthritis, muscle architecture, functionality, neuromuscular parameters

Brief summary

* The purpose of this study is to determine the effects of low-level laser therapy in combination with neuromuscular electrical stimulation on neuromuscular (muscular strength and morphology) and functional parameters (pain and functional tests) in elderly with knee osteoarthritis. * The hypothesis is that the association of low-level laser therapy with neuromuscular electrical stimulation could reduce joint pain associated with the inflammation and consequently potentiates the effects of electrical stimulation on the muscular system.

Detailed description

* Participants was randomized into one of three intervention groups (intervention period = 8 weeks after a 4 weeks control period in all groups). * Electrical stimulation group (18-32 min of pulsed current, stimulation frequency of 80Hz (Hertz), pulse duration of 200μs and stimulation intensity fixed near to maximal tolerated), * Laser group (low-level laser therapy dose of 4-6J (Joules) per point, six points at the knee joint) * Combined group (electrical stimulation and low-level laser therapy).

Interventions

OTHERLaser Therapy

Low-level laser therapy was administered twice a week with a minimum of 48h between sessions over a period of eight weeks.

OTHERElectrical Stimulation

Neuromuscular electrical stimulation was administered twice a week with a minimum of 48h between sessions over a period of eight weeks and with progressive intensity and volume.

Sponsors

Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
CollaboratorOTHER
Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
Marco Aurélio Vaz, PhD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
60 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* elderly. * symptomatic knee osteoarthritis. * radiographic diagnostic of Grade 2 or 3 knee osteoarthritis.

Exclusion criteria

* a body mass index higher than 40 Kg/m2. * a diagnosis of hip, ankle, or toe osteoarthritis. * the use of crutches for locomotion. * participation in a strength-training programme or physiotherapy treatment for knee osteoarthritis in the past six months. * neurological or cognitive disorders. * rheumatoid arthritis. * electronic implants. * previous or upcoming surgery (within three months). * any cardiorespiratory, neuromuscular, or metabolic disease that could represent an absolute contraindication or a contraindication to the performance of maximum strength tests.

Design outcomes

Primary

MeasureTime frameDescription
Torque changeTorque was measured 3 times during the study: baseline (week -4), before intervention (week 0) and post intervention (week 9).Torque is an expression of the muscular strength and was assessed by dynamometry.

Secondary

MeasureTime frameDescription
Muscular architecture changeArchitecture was measured 3 times during the study: baseline (week -4), before intervention (week 0) and post intervention (week 9).Muscular architecture (muscle thickness, pennation angle and fascicle length) were assessed by ultrasonography.

Other

MeasureTime frameDescription
Functional Performance changeFunctional performace was measured 3 times during the study: baseline (week -4), before intervention (week 0) and post intervention (week 9).Functional performance was assessed using the six-minute walk test and the Timed Up and Go test.
Pain ChangePain was measured 3 times during the study: baseline (week -4), before intervention (week 0) and post intervention (week 9).Pain was assessed by questionnaire
Muscular electrical activation changeMuscular electrical activation was measured 3 times during the study: baseline (week -4), before intervention (week 0) and post intervention (week 9)Electrical activation was assessed by electromyography (EMG).

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026